BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26965378)

  • 1. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
    Lodish M; Stratakis CA
    Nat Rev Endocrinol; 2016 May; 12(5):255-62. PubMed ID: 26965378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.
    Berthon A; Bertherat J
    Horm Metab Res; 2020 Aug; 52(8):598-606. PubMed ID: 32097969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal hyperplasias in childhood: An update.
    Pitsava G; Stratakis CA
    Front Endocrinol (Lausanne); 2022; 13():937793. PubMed ID: 35992119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
    Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
    N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiopathogeny of Primary Adrenal Hypercortisolism.
    Vélayoudom-Céphise FL; Haissaguerre M; Tabarin A
    Front Horm Res; 2016; 46():39-53. PubMed ID: 27212135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors.
    Rosenberg D; Groussin L; Bertagna X; Bertherat J
    Endocr Res; 2002 Nov; 28(4):765-75. PubMed ID: 12530696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.
    Lacroix A; Bourdeau I
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):441-58, x. PubMed ID: 15850852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
    Almeida MQ; Stratakis CA
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).
    Stratakis CA
    Endocr Dev; 2008; 13():117-132. PubMed ID: 18493137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
    Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
    BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report.
    Jin P; Janjua MU; Zhang Q; Dong CS; Yang Y; Mo ZH
    J Med Case Rep; 2018 Jan; 12(1):13. PubMed ID: 29343284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New insights in adrenal Cushing syndrome].
    Haissaguerre M; Tabarin A
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S37-45. PubMed ID: 25617921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.
    Liu Q; Tong D; Xu J; Yang X; Yi Y; Zhang D; Wang L; Zhang J; Zhang Y; Li Y; Chang L; Chen R; Guan Y; Yi X; Jiang J
    BMC Med Genet; 2018 Mar; 19(1):49. PubMed ID: 29587644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5th International ACC Symposium: The New Genetics of Benign Adrenocortical Neoplasia: Hyperplasias, Adenomas, and Their Implications for Progression into Cancer.
    Kirschner LS; Stratakis CA
    Horm Cancer; 2016 Feb; 7(1):9-16. PubMed ID: 26684645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of adrenocortical tumors.
    Espiard S; Bertherat J
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A defects and cortisol-producing adrenal tumors.
    Zilbermint M; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.